Autologous Orthobiologics Vs. Birth Tissue Products | Conversations in Regen Episode 3 episode artwork

EPISODE · Feb 22, 2025 · 56 MIN

Autologous Orthobiologics Vs. Birth Tissue Products | Conversations in Regen Episode 3

from The Business of Orthobiologics Podcast · host Ariana De Mers

Are you confused about the debate on autologous orthobiologics vs. birth tissue products? You’re not alone! Understanding the differences between these regenerative medicine options is essential for making informed decisions in musculoskeletal injury treatment.When it comes to regenerative medicine, how do you decide between using your patient’s own autologous tissue or opting for birth tissue products? Are birth tissue products truly effective, and what does the FDA say about their safety? If you’re in the field of musculoskeletal treatment, these questions are crucial for patient care. In this video, Dr. Ariana DeMers and Dr. Jason Dragoo break down the latest research, controversies, and upcoming innovations in orthobiologics and regenerative medicine. We dive deep into platelet-rich plasma injection therapy, best practices for PRP treatments, and how to navigate the ever-evolving orthobiologics market.We’ll explore the real science behind Platelet Rich Plasma injection injection therapy, its effectiveness in treating musculoskeletal injuries, and why PRP training courses are essential for professionals looking to expand their knowledge. Additionally, we’ll discuss the role of adipose-derived treatments, the potential return of birth tissue products in 2026, and the challenges of integrating these treatments into everyday clinical practice. What does the future hold for regenerative medicine techniques? How can orthobiologics and PRP injection therapy help patients avoid invasive surgeries? These are the questions we’ll address in this comprehensive discussion.Join us as we uncover the pros and cons of various orthobiologic treatments, from PRP training programs to autologous biologics, and discuss how to select the right patients for PRP injection therapy. We’ll also examine real-world case studies, explore the latest FDA regulations, and highlight strategies for ensuring the best patient outcomes. If you’re a healthcare provider, this discussion will give you valuable insights to enhance your practice and patient care.Don’t miss out—stay ahead in the growing field of regenerative medicine and musculoskeletal treatment! If you found this video helpful, be sure to like, comment, and subscribe for more insights on orthobiologics and regenerative medicine. Have questions? Drop them in the comments! Also, check out my training program in regenerative medicine for in-depth PRP course materials and expert guidance. Stay connected for future discussions on cutting-edge PRP injection therapy and regenerative treatment strategies!Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.Learn More here: https://thebusinessoforthobiologics.com/programs-explanation _______________________________________________________Follow us and subscribe to our links below ⏬⏬⏬Website: businessoforthobiologics.comApple Podcast: apple.co/3Azvt3RSpotify: spoti.fi/3oICYmhYoutube: bit.ly/drariana

Episode metadata supplied by the publisher feed · Published Feb 22, 2025

Embed this episode

Are you confused about the debate on autologous orthobiologics vs. birth tissue products? You’re not alone! Understanding the differences between these regenerative medicine options is essential for making informed decisions in musculoskeletal injury treatment. When it comes to regenerative medicine, how do you decide between using your patient’s own autologous tissue or opting for birth tissue products? Are birth tissue products truly effective, and what does the FDA say about their safety?...

Distinct summary based on available episode metadata or transcript content.

Ready to play

Autologous Orthobiologics Vs. Birth Tissue Products | Conversations in Regen Episode 3

0:00 56:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Business of Orthobiologics Podcast?

This episode is 56 minutes long.

When was this The Business of Orthobiologics Podcast episode published?

This episode was published on February 22, 2025.

Can I download this The Business of Orthobiologics Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!